GeneTex

  • Country / Location Selection

United States (US)

Zika virus Envelope protein antibody

Orthogonal
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314
Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314

Cat. No. GTX133314

Reference 99
6

Host

 Rabbit

Clonality

 Polyclonal

Isotype

 IgG

Application

 WB, ICC/IF, IHC-P

Reactivity

 Zika virus
Package
100 μl ($399),
25 μl ($169)
See all Zika virus Envelope protein products

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Recommended Dilution
WB 1:500-1:3000
ICC/IF 1:100-1:1000
IHC-P Assay dependent
Not tested in other applications.

Calculated MW

54 kDa. ( Note )

Positive Control

Zika virus Envelope-transfected 293T

PROPERTIES

Form

Liquid

Buffer

PBS, 1% BSA, 20% Glycerol

Preservative

0.025% ProClin 300

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Concentration

0.45 mg/ml (Please refer to the vial label for the specific concentration.)

Antigen Species

Zika virus

Immunogen

Carrier-protein conjugated synthetic peptide encompassing a sequence within the center region of Zika virus Envelope protein (Zika virus (strain H/PF/2013)). The exact sequence is proprietary.

Purification

Purified by antigen-affinity chromatography.

Conjugation

Unconjugated

RRID

AB_2747413

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Zika virus Envelope , ZIKV Envelope

Research Area

DATA IMAGES

Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314

GTX133314 WB Image

Mock and infected Vero and BHK-21 whole cell extracts (20 μg) were separated by gradient gel, and the membrane was blotted with Zika virus Envelope protein antibody (GTX133314) diluted at 1:4000.
This image was provided courtesy of cooperative research laboratories.

Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314

GTX133314 ICC/IF Image

Immunofluorescent analysis of Zika Virus-PRVABC59 infected (A) and non-infected (B) vero cells using Zika virus Envelope protein antibody (GTX133314).
Green: Zika virus Envelope protein antibody (GTX133314) diluted at 1:4000.
This image was provided courtesy of cooperative research laboratories.

Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314

GTX133314 WB Image

Non-infected (–) and infected (+) C6/36 whole cell extracts (30 μg) were separated by 10% SDS-PAGE, and the membrane was blotted with Zika virus Envelope protein antibody (GTX133314) diluted at 1:2000. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.

Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314

GTX133314 WB Image

Non-transfected (–) and transfected (+) 293T whole cell extracts (60 μg) were separated by 10% SDS-PAGE, and the membrane was blotted with Zika virus Envelope protein antibody (GTX133314) diluted at 1:5000. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.

Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314

GTX133314 ICC/IF Image

Immunofluorescent analysis of arboviruses infected cells using Zika virus Envelope protein antibody (GTX133314).
Samples: EUROIMMUN Arboviral Fever Mosaic 2 slide (FR 2668-1010-1).
Green: Zika virus Envelope protein antibody (GTX133314) diluted at 1:500.
Blue: Hoechst 33342 staining.
Scale bar = 10 μm.

Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314

GTX133314 ICC/IF Image

Immunofluorescent analysis of non-infected and infected vero or BHK-21 cells using Zika virus Envelope protein antibody (GTX133314).
Green: Zika virus Envelope protein antibody (GTX133314) diluted at 1:4000.
This image was provided courtesy of cooperative research laboratories.

Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314

GTX133314 WB Image

Non-infected (–) and infected (+) vero cells (15 μg) were separated by gradient gel, and the membrane was blotted with Zika virus Envelope protein antibody (GTX133314) diluted at 1:2000. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.
This image was provided courtesy of cooperative research laboratories.

Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314

GTX133314 ICC/IF Image

Immunofluorescent analysis of Zika virus infected cells using Zika virus NS5 protein antibody (GTX133314).
Sample: Mock and zika virus-infected cells.
Green: Zika virus Envelope protein antibody (GTX133314) diluted at 1:100.

Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314

GTX133314 WB Image

The data was published in the journal MBio in 2018.PMID: 30401782

Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314

GTX133314 WB Image

The data was published in the journal Emerg Microbes Infect in 2019. PMID: 30866755

Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314

GTX133314 WB Image

The data was published in the journal Front Pharmacol in 2019. PMID: 31249527

Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314

GTX133314 WB Image

The data was published in the journal mBio in 2017. PMID: 28698279

Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314

GTX133314 WB Image

The data was published in the journal Front Microbiol in 2019. PMID: 30984137

Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314

GTX133314 WB Image

The data was published in the journal Front Pharmacol in 2019. PMID: 31249527

Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314

GTX133314 WB Image

The data was published in the journal PLoS Negl Trop Dis in 2017.PMID: 28481898

Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314

GTX133314 WB Image

The data was published in the 2022 in Viruses. PMID: 35215967

REFERENCE

Application Reference

Zhang K et al. Molecules 2024; 29 (5) A Marine Natural Product, Harzianopyridone, as an Anti-ZIKV Agent by Targeting RNA-Dependent RNA Polymerase.
Ob?oza M et al. ACS Appl Mater Interfaces 2024; 16 (5) : 5426-5437 Curcumin-Poly(sodium 4-styrenesulfonate) Conjugates as Potent Zika Virus Entry Inhibitors.
H Zhu et al. BMC Biol 2024; 22 (1) : 12 The temporal association of CapZ with early endosomes regulates endosomal trafficking and viral entry into host cells
K Tabata et al. Appl Microbiol Biotechnol 2023; Development of flavivirus subviral particles with low cross-reactivity by mutations of a distinct antigenic domain
J Jaratsittisin et al. PLoS One 2023; The vitamin D receptor agonist EB1089 can exert its antiviral activity independently of the vitamin D receptor
Application : WB, ICC/IF
Show More +
Submit a Reference

REVIEW

Zika virus Envelope protein antibody Cat. No. GTX133314

Rating
( Average 4.8 based on 6 users reviews)
Application
Western Blot(WB)
( Average 4.7 based on 3 users reviews)
Immunocytochemistry/ Immunofluorescence(ICC/IF)
( Average 5 based on 3 users reviews)
Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314
Date : Anonymous submitted on 03-Apr-2018
Score :
Application Tested : ICC/IF
Sample Species : ZIKV
Sample : Zika Virus-MR-766 infected BHK-21 cells
Fixation : 4% paraformaldehyde, 0.5Hr
Permeabilization /Antigen retrieval : 0.1% Triton X-100, 4°C, 2 hrHr
Primary Antibody : 1:3000, 4°C, 16Hr
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Date : Anonymous submitted on 14-Jun-2016
Score :
Application Tested : WB
Sample Species : ZIKV
Sample : ZIKV-infected vero cells, ZIKV-infected BHK21 cells
Blocking : 5% non-fat milk
Primary Antibody : 1:4000, 4°C, 16Hr
Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314
Date : Anonymous submitted on 13-Jun-2016
Score :
Application Tested : ICC/IF
Sample Species : ZIKV
Sample : ZIKV-infected vero cells, ZIKV-infected BHK21 cells
Blocking : 3% BSA in PBS
Primary Antibody : 1:4000, 4°C, 16Hr
Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314
Date : Anonymous submitted on 04-Jun-2016
Score :
Application Tested : ICC/IF
Sample Species : ZIKV
Sample : Zika Virus-PRVABC59 infected vero cells
Fixation : methanol + acetone
Primary Antibody : 1:4000, 4°C, 16Hr
Figure Note : A: Zika Virus-PRVABC59 infected vero cells. (MOI=1 24h), B: vero cell
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Date : Anonymous submitted on 04-Jun-2016
Score :
Application Tested : WB
Sample Species : ZIKV
Sample : Zika Virus-PRVABC59 infected C6/36 cells
Amount used : 20μg
Blocking : 5% non-fat milk
Primary Antibody : 1:4000, 4°C, 16Hr
Lane Description : Lane 1: C6/36 cells, Lane 2: Zika Virus-PRVABC59 infected C6/36 cells
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Date : Anonymous submitted on 02-Jun-2016
Score :
Application Tested : WB
Sample Species : ZIKV
Sample : Zika Virus-PRVABC59 infected vero cells
Amount used : 15μg
Blocking : 5% non-fat milk, 25°C, 0.5Hr
Primary Antibody : 1:2000, 4°C, 16Hr
Lane Description : Lane 1: vero cells, Lane 2: Zika Virus-PRVABC59 infected vero cells. (MOI=0.1 96h)
Show More +
Submit a Review
Application Reference
Zhang K et al. Molecules 2024; 29 (5) A Marine Natural Product, Harzianopyridone, as an Anti-ZIKV Agent by Targeting RNA-Dependent RNA Polymerase.
Ob?oza M et al. ACS Appl Mater Interfaces 2024; 16 (5):5426-5437 Curcumin-Poly(sodium 4-styrenesulfonate) Conjugates as Potent Zika Virus Entry Inhibitors.
H Zhu et al. BMC Biol 2024; 22 (1):12 The temporal association of CapZ with early endosomes regulates endosomal trafficking and viral entry into host cells
K Tabata et al. Appl Microbiol Biotechnol 2023; Development of flavivirus subviral particles with low cross-reactivity by mutations of a distinct antigenic domain
J Jaratsittisin et al. PLoS One 2023; The vitamin D receptor agonist EB1089 can exert its antiviral activity independently of the vitamin D receptor
Application : WB, ICC/IF
Wu H et al. Nat Commun 2023; 14 (1):5541 Zika virus targets human trophoblast stem cells and prevents syncytialization in placental trophoblast organoids.
Li H et al. Signal Transduct Target Ther 2023; 8 (1):374 Secreted LRPAP1 binds and triggers IFNAR1 degradation to facilitate virus evasion from cellular innate immunity.
Kaur G et al. Front Cell Neurosci 2023; 17:1173120 Zika virus E protein modulates functions of human brain microvascular endothelial cells and astrocytes: implications on blood-brain barrier properties.
Narayan R et al. Cell Rep Med 2023; 4 (8):101127 Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in?vivo.
IJ Kim et al. NPJ Vaccines 2023; Zika purified inactivated virus (ZPIV) vaccine efficacy in pregnant human stat2 knock-in mice: neutralizing antibodies as correlates of protection
Application : IHC-P
Yujia Zhu et al. Eur J Med Chem 2023;:115620 Design, synthesis, and biological evaluation of a series of new anthraquinone derivatives as anti-ZIKV agents
Application : WB
Zhu Y et al. Viruses 2023; 15 (5) Repurposing of Doramectin as a New Anti-Zika Virus Agent.
Gilbert-Jaramillo J et al. Biol Open 2023; 12 (4) Zika virus-induces metabolic alterations in fetal neuronal progenitors that could influence in neurodevelopment during early pregnancy.
Lin DC et al. Parasit Vectors 2023; 16 (1):160 Co-infection of dengue and Zika viruses mutually enhances viral replication in the mosquito Aedes aegypti.
Chen T et al. Virol Sin 2023; 38 (2):222-232 Splicing factor SF3B3, a NS5-binding protein, restricts ZIKV infection by targeting GCH1.
Pan P et al. Signal Transduct Target Ther 2023; 8 (1):194 SARS-CoV-2 N protein enhances the anti-apoptotic activity of MCL-1 to promote viral replication.
Hu D et al. Viruses 2023; 15 (1) ZDHHC11 Suppresses Zika Virus Infections by Palmitoylating the Envelope Protein.
Application : WB
Fu Y et al. PLoS Pathog 2023; 19 (1):e1011090 Exosomes mediate Coxsackievirus B3 transmission and expand the viral tropism.
Application : WB
Chen W et al. Virol Sin 2023; 38 (1):23-33 Zika virus non-structural protein 4B interacts with DHCR7 to facilitate viral infection.
Application : WB
Zhang B et al. Molecules 2023; 28 (24) Dapoxetine, a Selective Serotonin Reuptake Inhibitor, Suppresses Zika Virus Infection In Vitro.
Lima MLD et al. Braz J Microbiol 2022; 53 (3):1279-1287 Early infection of Zika virus in the male reproductive system of AG129 mice: molecular and immunohistochemical evaluation.
Polonio CM et al. Int J Mol Sci 2022; 23 (18) microRNAs Control Antiviral Immune Response, Cell Death and Chemotaxis Pathways in Human Neuronal Precursor Cells (NPCs) during Zika Virus Infection.
Application : ICC/IF
Wang J et al. J Biol Chem 2022; 298 (10):102471 A cathelicidin antimicrobial peptide from Hydrophis cyanocinctus inhibits Zika virus infection by downregulating expression of a viral entry factor.
Huang Y et al. Virol Sin 2022; 37 (6):904-912 A novel IFNbeta-induced long non-coding RNA ZAP-IT1 interrupts Zika virus replication in A549 cells.
Rangel MV et al. J Virol 2022; 96 (2):e0177421 Structurally Conserved Domains between Flavivirus and Alphavirus Fusion Glycoproteins Contribute to Replication and Infectious-Virion Production.
Wikan N et al. Pharmaceutics 2022; 14 (12) Alpinetin Suppresses Zika Virus-Induced Interleukin-1β Production and Secretion in Human Macrophages.
Gao SS et al. iScience 2022; 25 (12):105481 GPI-anchored ligand-BioID2-tagging system identifies Galectin-1 mediating Zika virus entry.
Zhou S et al. Virol Sin 2022; 37 (5):685-694 Rottlerin plays an antiviral role at early and late steps of Zika virus infection.
Watts JL et al. Development 2022; 149 (14) The fetal lineage is susceptible to Zika virus infection within days of fertilization.
Rui Zhou et al. Bioorg Chem. 2022; 128 Repurposing of the antihistamine mebhydrolin napadisylate for treatment of Zika virus infection
Application : WB
Mahamud-Ur Rashid et al. Viruses 2022; 14 (2) Zika Virus Infection of Sertoli Cells Alters Protein Expression Involved in Activated Immune and Antiviral Response Pathways, Carbohydrate Metabolism and Cardiovascular Disease.
Application : WB
Frias IAM et al. ACS Appl Mater Interfaces 2022; 14 (1):41-48 Self-Enriching Electrospun Biosensors for Impedimetric Sensing of Zika Virus.
Jia Quan et al. Virol Sin 2021; 36 (5):1165-1176 Cucurbit[7]uril as a Broad-Spectrum Antiviral Agent against Diverse RNA Viruses.
Application : WB
Xi Yu et al. Proc Natl Acad Sci U S A 2021; 118 (42) A mutation-mediated evolutionary adaptation of Zika virus in mosquito and mammalian host.
Application : WB
Philma Glora Muthuraj et al. Cell Death Discov 2021; 7 (1):24 Zika virus infection induces endoplasmic reticulum stress and apoptosis in placental trophoblasts.
Application : WB, ICC/IF
Hongli Jin et al. PLoS Negl Trop Dis 2021; 15 (6):e0009484 An inactivated recombinant rabies virus displaying the Zika virus prM-E induces protective immunity against both pathogens.
Application : WB, ICC/IF
Dingwen Hu et al. Virulence 2021; 12 (1):1795-1807 LAMR1 restricts Zika virus infection by attenuating the envelope protein ubiquitination.
Application : WB, ICC/IF
Yingchong Wang et al. Viruses 2021; 13 (10) USP38 Inhibits Zika Virus Infection by Removing Envelope Protein Ubiquitination.
Application : WB
Zhang JW et al. Virol Sin 2021; 36 (3):476-489 Generation of A Stable GFP-reporter Zika Virus System for High-throughput Screening of Zika Virus Inhibitors.
Lu JW et al. Antiviral Res 2021; 195:105188 Synergistic in-vitro antiviral effects of combination treatment using anidulafungin and T-1105 against Zika virus infection.
Porier DL et al. Vaccines (Basel) 2021; 9 (10) Enemy of My Enemy: A Novel Insect-Specific Flavivirus Offers a Promising Platform for a Zika Virus Vaccine.
Application : WB
Wang Y. et al. biochemistry 2021; (Epub) USP38 Inhibits Zika Virus Infection by Removing Envelope Protein Ubiquitination.
Gao J et al. Virol J 2021; 18 (1):151 Construction of an infectious clone of Zika virus stably expressing an EGFP marker in a eukaryotic expression system.
Application : WB
Mladinich MC et al. mBio 2021; 12 (4):e0196221 Blockade of Autocrine CCL5 Responses Inhibits Zika Virus Persistence and Spread in Human Brain Microvascular Endothelial Cells.
Application : WB
Singh S et al. Biomolecules 2021; 11 (5) Povidone-Iodine Attenuates Viral Replication in Ocular Cells: Implications for Ocular Transmission of RNA Viruses.
Application : ICC/IF
Jasperse B et al. Sci Rep 2021; 11 (1):6492 Single dose of a replication-defective vaccinia virus expressing Zika virus-like particles is protective in mice.
Shin HJ et al. Microorganisms 2021; 9 (3) Structure-Based Virtual Screening: Identification of a Novel NS2B-NS3 Protease Inhibitor with Potent Antiviral Activity against Zika and Dengue Viruses.
Application : WB
Oh SJ et al. Cells 2021; 10 (3) SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response.
Application : WB
Huang L et al. Cell Biol Toxicol 2021; High-content screening of diterpenoids from Isodon species as autophagy modulators and the functional study of their antiviral activities.
Application : WB
Khongwichit S et al. Sci Rep 2021; 11 (1):393 A functional interaction between GRP78 and Zika virus E protein.
Application : WB
Drouin A et al. Cytokine 2021; 137:155342 Impact of Zika virus on the human type I interferon osteoimmune response.
Application : IHC-P
Chuang FK et al. Int J Mol Sci 2020; 21 (11):4050 Antiviral Activity of Compound L3 against Dengue and Zika Viruses In Vitro and In Vivo
Application : WB
Kabir MA et al. Sci Rep 2020; 10 (1):11906 An antibody panel for highly specific detection and differentiation of Zika virus.
Clark AE et al. J Virol 2020; (Epub) Zika virus is transmitted in neural progenitor cells via cell-to-cell spread and infection is inhibited by the autophagy inducer trehalose.
Application : WB
Sun F et al. Viruses 2020; 12 (3) Topology, Antiviral Functional Residues and Mechanism of IFITM1.
Lingel A et al. J Biol Chem 2020; 295 (50):17114-17127 Amyloid precursor protein is a restriction factor that protects against Zika virus infection in mammalian brains.
Application : ICC/IF
Huang Y et al. J Virol 2020; 94 (23) Inositol-Requiring Enzyme 1α Promotes Zika Virus Infection through Regulation of Stearoyl Coenzyme A Desaturase 1-Mediated Lipid Metabolism.
Application : WB
Srivastava M et al. Nat Commun 2020; 11 (1):3896 Chemical proteomics tracks virus entry and uncovers NCAM1 as Zika virus receptor.
Application : WB
Zeng J et al. Cell Stem Cell 2020; 27 (4):618-632.e9 The Zika Virus Capsid Disrupts Corticogenesis by Suppressing Dicer Activity and miRNA Biogenesis.
Application : WB
Botwina P et al. Viruses 2020; 12 (9) In Vitro Inhibition of Zika Virus Replication with Poly(Sodium 4-Styrenesulfonate).
Application : ICC/IF
Chen J et al. mBio 2020; 11 (5) Placental Alkaline Phosphatase Promotes Zika Virus Replication by Stabilizing Viral Proteins through BIP.
Application : ICC/IF
Jia He et al. Autophagy 2020; (Epub) Zika virus NS2A protein induces the degradation of KPNA2 (karyopherin subunit alpha 2) via chaperone-mediated autophagy.
Application : WB
Chen H et al. Virology 2020; 546:88-97 Antiviral activity of lycorine against Zika virus in vivo and in vitro.
Application : WB
Wu Y et al. PLoS Negl Trop Dis 2020; 14 (3):e0008083 C19orf66 interrupts Zika virus replication by inducing lysosomal degradation of viral NS3.
Application : WB
Garg H et al. Sci Rep 2020; 10 (1):4017 Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika Virus.
Application : WB
Chiu CF et al. Front Microbiol 2020; 11:214 The Mechanism of the Zika Virus Crossing the Placental Barrier and the Blood-Brain Barrier.
Application : WB, ICC/IF
Li C et al. Antimicrob Agents Chemother 2019; (Epub) Azithromycin Protects against Zika virus Infection by Upregulating virus-induced Type I and III Interferon Responses.
Lin JY et al. Stem Cell Res Ther 2019; 10 (1):387 Activation of type I interferon antiviral response in human neural stem cells.
Application : ICC/IF
Lu CY et al. Viruses 2019; 11 (11) The Rescue and Characterization of Recombinant, Microcephaly-Associated Zika Viruses as Single-Round Infectious Particles.
Application : WB
Pujhari S et al. Emerg Microbes Infect 2019; 8 (1):8-16 Heat shock protein 70 (Hsp70) mediates Zika virus entry, replication, and egress from host cells.
Strange DP et al. MBio 2019; 10 (4) Axl Promotes Zika Virus Entry and Modulates the Antiviral State of Human Sertoli Cells.
Khaiboullina S et al. Front Pharmacol 2019; 10:642 Transcriptome Profiling Reveals Pro-Inflammatory Cytokines and Matrix Metalloproteinase Activation in Zika Virus Infected Human Umbilical Vein Endothelial Cells.
Chuang FK et al. Antimicrob Agents Chemother 2019; (Epub) Anti-inflammatory compound shows therapeutic safety and efficacy against flavivirus infection.
Application : WB
Routhu NK et al. Int J Mol Sci 2019; 20 (20) Glycosylation of Zika Virus is Important in Host-Virus Interaction and Pathogenic Potential.
Zhang X et al. MBio 2019; 10 (5) Zika Virus NS2A-Mediated Virion Assembly.
Application : WB, ICC/IF
Garg H et al. Vaccine 2019; Capsid containing virus like particle vaccine against Zika virus made from a stable cell line.
Application : WB
Sher AA et al. Front Microbiol 2019; 10:596 Zika Virus Infection Disrupts Astrocytic Proteins Involved in Synapse Control and Axon Guidance.
Application : WB
Ojha CR et al. PLoS One 2019; 14 (2):e0208543 Toll-like receptor 3 regulates Zika virus infection and associated host inflammatory response in primary human astrocytes.
Application : ICC/IF
Taguwa S et al. Cell Rep 2019; 26 (4):906-920.e3 Zika Virus Dependence on Host Hsp70 Provides a Protective Strategy against Infection and Disease.
Application : WB, ICC/IF
Li F et al. J Biol Chem 2019; 294 (1):182-194 A scorpion venom peptide Ev37 restricts viral late entry by alkalizing acidic organelles.
Application : WB
Tangsongcharoen C et al. Biochim Biophys Acta Proteins Proteom 2019; 1867 (2):89-97 Analysis of cellular proteome changes in response to ZIKV NS2B-NS3 protease expression.
Application : WB
Fontaine KA et al. MBio 2018; 9 (6) The Cellular NMD Pathway Restricts Zika Virus Infection and Is Targeted by the Viral Capsid Protein.
Application : WB
Li P et al. Cell Host Microbe 2018; 24 (6):875-886.e5 Integrative Analysis of Zika Virus Genome RNA Structure Reveals Critical Determinants of Viral Infectivity.
Application : WB
N?rnberger C et al. J Virol 2018; (Epub) A measles virus-based vaccine candidate mediates protection against Zika virus in an allogenic mouse pregnancy model.
Application : WB
Khachatoorian R et al. Virology 2018; 522:228-233 HSP70 Copurifies with Zika Virus Particles.
Application : WB
Mazar J et al. PLoS One 2018; 13 (7):e0200358 Zika virus as an oncolytic treatment of human neuroblastoma cells requires CD24.
Application : WB, ICC/IF
Routhu NK et al. Mol Pharm 2018; (Epub) Polymeric Prodrugs Targeting Polyamine Metabolism Inhibit Zika Virus Replication.
Application : ICC/IF
Chambers MT et al. J Virol 2018; (Epub) Probing Zika virus neutralization determinants with glycoprotein mutants bearing linear epitope insertions.
Application : WB
Huang Y et al. Cell Discov 2018; 4:19 Zika virus propagation and release in human fetal astrocytes can be suppressed by neutral sphingomyelinase-2 inhibitor GW4869.
Application : WB
Wichgers Schreur PJ et al. Emerg Microbes Infect 2018; 7 (1):42 Microencephaly in fetal piglets following in utero inoculation of Zika virus.
Application : ICC/IF
Fontaine K.A. et al. bioRxiv 2018; (Epub) The cellular NMD pathway restricts Zika virus infection and is targeted by the viral capsid protein.
Application : WB
Jin L et al. Nat Immunol 2018; (Epub) Salivary factor LTRIN from Aedes aegypti facilitates the transmission of Zika virus by interfering with the lymphotoxin-β receptor.
Application : WB
Boigard H et al. PLoS Negl Trop Dis 2017; 11 (5):e0005608 Zika virus-like particle (VLP) based vaccine.
Tabata T et al. J Infect Dis 2017; (Epub) Zika Virus Replicates in Proliferating Cells in Explants from First-trimester Human Placentas, Potential Sites for Dissemination of Infection.
Garg H et al. J Virol 2017; (Epub) Development of Virus like Particle Vaccine and Reporter Assay for Zika Virus.
Application : WB
Mladinich MC et al. MBio 2017; 8 (4) Zika Virus Persistently Infects and Is Basolaterally Released from Primary Human Brain Microvascular Endothelial Cells.
Application : WB
Estoppey D et al. Cell Rep 2017; 19 (3):451-460 The Natural Product Cavinafungin Selectively Interferes with Zika and Dengue Virus Replication by Inhibition of the Host Signal Peptidase.
Application : WB
Chahal JS et al. Sci Rep 2017; 7 (1):252 An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse model.
Application : WB
Boigard H et al. PLoS Negl Trop Dis 2017; (Epub) Zika virus-like particle (VLP) based vaccine.
Application : WB
SDS
PBS.pdf
Glycerol.pdf
Proclin.pdf
Package List Price ($)
$ 399
$ 169